DocGo Inc. reports results for the quarter ended June 30 - Earnings Summary
DocGo Inc. reports results for the quarter ended June 30 - Earnings Summary
DocGo Inc. DCGO.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -11 cents. The mean expectation of five analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -11 cents to 4 cents per share.
Revenue fell 8.7% to $73.42 million from a year ago; analysts expected $75.40 million.
DocGo Inc.'s reported EPS for the quarter was a loss of 16 cents.
The company reported a quarterly loss of $15.82 million.
DocGo Inc. shares had risen by 29.3% this quarter and lost 24.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for DocGo Inc. is $1.75, about 61.9% above its last closing price of $0.67
This summary was machine generated from LSEG data August 17 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.06 | -0.16 | Missed |
Mar. 31 2026 | -0.09 | -0.13 | Missed |
Dec. 31 2025 | -0.13 | -1.37 | Missed |
Sep. 30 2025 | -0.12 | -0.11 | Beat |
Recent news on DocGo
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
U.S. STOCKS ON THE MOVE-Dynatrace, Duolingo, Baidu Inc
DocGo slips on tepid quarterly results, narrower annual outlook